To include your compound in the COVID-19 Resource Center, submit it here.
RegenxBio Inc. (NASDAQ:RGNX) will acquire Dimension Therapeutics Inc. (NASDAQ:DMTX) in a stock deal. For each share held, Dimension shareholders will receive 0.1573 RegenxBio shares, which the companies
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury